BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35005320)

  • 1.
    Steele C; You Z; Gitomer BY; Brosnahan GM; Abebe KZ; Braun WE; Chapman AB; Harris PC; Perrone RD; Steinman TI; Torres VE; Yu ASL; Chonchol M; Nowak KL
    Kidney Int Rep; 2022 Jan; 7(1):117-120. PubMed ID: 35005320
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
    Grau L; Gitomer B; McNair B; Wolf M; Harris P; Brosnahan G; Torres V; Steinman T; Yu A; Chapman A; Chonchol M; Nowak KL
    Kidney360; 2020 Jul; 1(7):648-656. PubMed ID: 33305291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
    Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
    J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
    Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
    Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History.
    Sekine A; Fujimaru T; Hoshino J; Suwabe T; Oguro M; Mizuno H; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
    Am J Nephrol; 2019; 49(3):233-240. PubMed ID: 30820006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mutations in six Chinese families with autosomal dominant polycystic kidney disease.
    Wang H; Dai S; Zhang J; Li Y; Gan Y; Lu T; Zhu Y; Wu J; Lin N; Tang F; Luo J
    Am J Transl Res; 2020; 12(12):8123-8136. PubMed ID: 33437386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis and prognosis of autosomal dominant polycystic kidney disease.
    Parfrey PS; Bear JC; Morgan J; Cramer BC; McManamon PJ; Gault MH; Churchill DN; Singh M; Hewitt R; Somlo S
    N Engl J Med; 1990 Oct; 323(16):1085-90. PubMed ID: 2215575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of kidney disease varies between families with defects in the polycystic kidney disease type 1 gene in eastern Finland.
    Lumiaho A; Ikäheimo R; Pihlajamäki J; Miettinen R; Niemitukia L; Vanninen R; Lampainen E; Laakso M
    Scand J Urol Nephrol; 2003; 37(4):352-8. PubMed ID: 12944197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease.
    Miyamoto R; Sekine A; Fujimaru T; Suwabe T; Mizuno H; Hasegawa E; Yamanouchi M; Chiga M; Mori T; Sohara E; Uchida S; Sawa N; Ubara Y; Hoshino J
    Kidney Dis (Basel); 2022 May; 8(3):246-252. PubMed ID: 35702705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
    Sekine A; Hoshino J; Fujimaru T; Suwabe T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
    Am J Nephrol; 2020; 51(9):745-751. PubMed ID: 32784291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic linkage analysis, clinical features and prognosis of autosomal dominant polycystic kidney disease in Northern Ireland.
    Wright GD; Hughes AE; Larkin KA; Doherty CC; Nevin NC
    Q J Med; 1993 Jul; 86(7):459-63. PubMed ID: 8210302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Genotype-phenotype characteristics of nine novel
    Zhuang J; Aierken A; Yalikun D; Zhang J; Wang X; Ren Y; Tian X; Jiang H
    Front Med (Lausanne); 2023; 10():1268307. PubMed ID: 37901409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
    Bae KT; Zhou W; Shen C; Landsittel DP; Wu Z; Tao C; Chapman AB; Torres VE; Yu ASL; Mrug M; Bennett WM; Harris PC;
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):823-833. PubMed ID: 31088850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
    Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
    J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
    Chapman AB
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1197-204. PubMed ID: 18579674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype.
    Kremer LE; Chapman AB; Armato SG
    J Med Imaging (Bellingham); 2023 Nov; 10(6):064503. PubMed ID: 38156331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease.
    Ravine D; Walker RG; Gibson RN; Forrest SM; Richards RI; Friend K; Sheffield LJ; Kincaid-Smith P; Danks DM
    Lancet; 1992 Nov; 340(8831):1330-3. PubMed ID: 1360045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations.
    Kataoka H; Fukuoka H; Makabe S; Yoshida R; Teraoka A; Ushio Y; Akihisa T; Manabe S; Sato M; Mitobe M; Tsuchiya K; Nitta K; Mochizuki T
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31948117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large deletion of Wdr19 in developing renal tubules disrupts primary ciliogenesis, leading to polycystic kidney disease in mice.
    Yu SS; Wang E; Chiang CY; Cheng PH; Yeh YS; Wu YY; Chiou YY; Jiang ST
    J Pathol; 2022 May; 257(1):5-16. PubMed ID: 35007346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.